Mathilde Cailliez, M.D. – FDA Inspection, Jun 5, 2026

Record Details

This FDA Inspection record concerns Mathilde Cailliez, M.D., with an inspection on June 5, 2026, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Mathilde Cailliez, M.D.
Inspection Date: June 5, 2026
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Brittany L. Carpenter (Company Rep)

View Company Profile

ID · ef930f7d-78a8-416c-8fc1-9e8307de97c0

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1320528
FDA center: Human Drugs
Project area: Bioresearch Monitoring
Outcome: Form 483 issued

FDA Citations

21 CFR 50.27(b)(2)Short form: Oral presentation/signing

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Mathilde Cailliez, M.D.

FDA Inspection

Mathilde Cailliez, M.D.June 5, 2026